Shenzhen Magicrna Biotechnology Co Ltd

We track 1 ClinicalTrials.gov studies led by Shenzhen Magicrna Biotechnology Co Ltd. The portfolio skews toward Phase 1 (1 trials).

1 clinical trials sponsored by Shenzhen Magicrna Biotechnology Co Ltd.

Pipeline by Phase

PhaseTrialsDistribution
Phase 1 1
100%

Trial Status Breakdown

Trials by Shenzhen Magicrna Biotechnology Co Ltd

Dose-escalation Study to Assess the Safety, Tolerability, and Preliminary Efficacy of HN2301 in Patients With Autoimmune Diseases Including Systemic Lupus Erythematosus（SLE）, Systemic Sclerosis (SSc) and Rheumatoid Arthritis （RA）

NCT06801119 · RECRUITING · Phase 1

Frequently Asked Questions

How many clinical trials does Shenzhen Magicrna Biotechnology Co Ltd sponsor?

Shenzhen Magicrna Biotechnology Co Ltd currently sponsors 1 clinical trials tracked on ReadTheTrial. These span Phase 1.

What conditions does Shenzhen Magicrna Biotechnology Co Ltd research?

Shenzhen Magicrna Biotechnology Co Ltd conducts research across multiple therapeutic areas. Browse the trial listings for details.

Is Shenzhen Magicrna Biotechnology Co Ltd recruiting for clinical trials?

Yes, Shenzhen Magicrna Biotechnology Co Ltd currently has 1 trial that are actively recruiting participants. Check individual trial pages for eligibility criteria and locations.

Explore More